InvestorsHub Logo

iandy

06/04/12 2:32 PM

#19382 RE: adreamer #19381

The markets green and this POS is acting like a pig again.

JJM760

06/04/12 2:32 PM

#19383 RE: adreamer #19381

Would you be so kind as to pass that "next front line molecule" stuff on to the insurance companies who will fight tooth and nail to make sure that title is given to generic Gleevec for as long as humanly possible.

The fight for the front line will be a difficult one regardless of the fact that Ponatinib is most likely as we speak best in class.

thesaud

06/04/12 2:33 PM

#19384 RE: adreamer #19381

perhaps investors are waiting for the fda ruling on rida b4 buying, maybe a lower price on the news?